Welcome to our dedicated page for Davita news (Ticker: DVA), a resource for investors and traders seeking the latest updates and insights on Davita stock.
DaVita Inc. provides comprehensive kidney care through a global dialysis and care-delivery network. Company news commonly covers quarterly operating results, revenue per treatment, patient care costs, reimbursement trends, share repurchases and investor conference participation.
Updates also address DaVita's value-based kidney care programs, coordinated care arrangements, and services that support patients across stages and settings of kidney disease, including home support, outpatient dialysis centers, hospitals, skilled nursing facilities and transplantation-related care.
DaVita Kidney Care announces the appointment of Tina Livaudais as the new chief nursing officer (CNO) during Nephrology Nurses Week. Livaudais brings over 26 years of experience with DaVita, serving in various clinical and leadership roles. As CNO, she aims to enhance clinical excellence and professional growth for nursing staff. The company continues to focus on improving patient care, aiming to be the preferred provider and employer in the kidney care sector. DaVita operates 2,828 outpatient dialysis centers in the U.S., caring for over 204,300 patients.
DaVita Inc. appointed Dr. Gregory Moore as an independent director effective Sept. 9, 2021. With nearly 20 years of healthcare experience, Dr. Moore currently leads Microsoft's Health & Life Sciences division, focusing on digital transformation in healthcare. CEO Javier Rodriguez emphasized that Dr. Moore's expertise will enhance DaVita's efforts to innovate kidney care solutions. Dr. Moore will participate in the Nominating and Governance Committee and the Compliance and Quality Committee. This addition strengthens the Board's diversity, with 33% racial/ethnic and 44% gender representation.
DaVita reported strong financial results for Q2 2021, with diluted earnings per share of $2.64, a 63% increase year-over-year. Consolidated revenues reached $2.917 billion, while operating income was $490 million. The company experienced a solid operating cash flow of $680 million and free cash flow of $503 million. DaVita's ongoing investment in integrated kidney care is expected to drive growth, increasing patients under value-based care arrangements to approximately 10% of its U.S. dialysis patient base. The company also repurchased over 2 million shares this quarter.
DaVita Inc. (NYSE: DVA) announced a quarterly conference call to discuss its second quarter results on August 3, 2021, at 5:00 p.m. Eastern Time. The results will be released after market close on the same day. Investors can join the call via phone or webcast. DaVita is focused on improving kidney care services, treating patients with chronic kidney failure, and has become the leading provider of home dialysis in the U.S., serving over 202,600 patients across 2,827 outpatient dialysis centers.
DaVita and the National Kidney Foundation (NKF) have partnered to launch a yearlong pilot program aimed at enhancing health equity in kidney transplantation. This initiative will be implemented in Colorado, New York, Minnesota, and New Mexico, focusing on empowering kidney patients to find living donors. The program will offer extensive support, including one-on-one guidance from Patient Navigators and access to a new web platform for education. With over 500,000 individuals in the U.S. living with kidney failure and nearly 100,000 awaiting a transplant, this collaboration seeks to improve donor accessibility and patient outcomes.
On June 2, 2021, DaVita Kidney Care launched virtual support groups via its DaVita Care Connect platform, aimed at enhancing community among home dialysis patients. These sessions, facilitated by home support specialists, provide a space for live discussions on topics such as stress management and the path to kidney transplants. Over 50% of DaVita's home patients currently utilize digital platforms for care. This initiative reflects DaVita's commitment to improving the home dialysis experience and fostering patient connection.
DaVita Kidney Care announced the recognition of 60 nephrology nurses with The DAISY Award during National Nurses Week. This award celebrates the extraordinary care these nurses provide to patients. Each honoree received a personalized certificate, a DAISY Award pin, and a hand-carved sculpture. DaVita, one of the largest kidney care service providers in the U.S., serves over 202,600 patients across 2,827 outpatient dialysis centers. The company is committed to improving patient care through innovative practices and reducing hospitalizations.
DaVita Kidney Care announced the expansion of its home kidney care program with the HomeChoice Claria Automated Peritoneal Dialysis (APD) system, enhanced by Sharesource remote patient monitoring technology from Baxter International. This initiative aims to empower patients to manage kidney failure at home, offering improved connectivity between patients and care teams. Currently, DaVita is utilizing this technology with over 250 patients across the U.S., focusing on enhancing the quality of life for individuals undergoing peritoneal dialysis.
DaVita reported Q1 2021 results showing diluted EPS from continuing operations at $2.09, a 15.5% increase YoY. Consolidated revenues reached $2.820 billion, while operating income was $443 million. Operating cash flow fell to $154 million, and free cash flow was negative at $(17) million, impacted by COVID-19. The company repurchased nearly 3 million shares at an average cost of $109.28. Although the pandemic posed challenges, DaVita successfully vaccinated nearly 75% of its U.S. dialysis patients, enhancing health equity.
Summary not available.